SELLAS Life Sciences Group, Inc. (SLS) — Financial statements
Income statement, balance sheet, and cash flow for SELLAS Life Sciences Group, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 0.00 | 0.00 | 0.00↓100.0% | 1↓86.8% | 8 | |
| Cost of Revenue | 0.00 | 0.00 | 0.00↓100.0% | 0.10↓50.0% | 0.20 | |
| Gross Profit | 0.00 | 0.00 | 0.00↓100.0% | 0.90↓87.8% | 7 | |
| Operating Expenses | ||||||
| R&D Expenses | 16↓16.1% | 19↓20.5% | 24↓20.7% | 30↑41.6% | 21 | |
| General & Administrative Expenses | 12↓1.3% | 12↓10.4% | 14↑10.2% | 13↑11.1% | 11 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 12↓1.3% | 12↓10.4% | 14↑10.2% | 13↑11.1% | 11 | |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 28↓10.3% | 32↓16.8% | 38↓11.6% | 43↑31.1% | 33 | |
| Total Costs & Expenses | 28↓10.3% | 32↓16.8% | 38↓11.8% | 43↑30.6% | 33 | |
| Operating Results | ||||||
| Operating Income | -28↑10.3% | -32↑16.8% | -38↑9.7% | -42↓65.8% | -25 | |
| Depreciation & Amortization | 0.00↓100.0% | 32↓16.8% | 38↑8186.4% | 0.46↓64.1% | 1 | |
| EBITDA | -28↓4573.7% | 0.63↑19.5% | 0.53↑101.7% | -31↓71.9% | -18 | |
| EBIT | -28↑8.4% | -31↑17.3% | -37↓16.9% | -32↓63.1% | -20 | |
| Interest & Other Income | ||||||
| Net Interest Income | 1↑123.3% | 0.63↑20.4% | 0.53↑65.6% | 0.32↑5183.3% | 0.01 | |
| Interest Income | 1↑123.3% | 0.63↑20.4% | 0.53↑65.6% | 0.32↑5183.3% | 0.01 | |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Non-Operating Income | 0.00↑100.0% | -0.63↓19.5% | -0.53↑94.7% | -10↓75.4% | -6 | |
| Other Income / Expenses | 1↑123.3% | 0.63↑19.5% | 0.53↓18.5% | 0.65↓85.1% | 4 | |
| Income Before Tax | -27↑13.0% | -31↑17.3% | -37↑9.6% | -41↓97.3% | -21 | |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00↑100.0% | -0.24 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -27↑13.0% | -31↑17.3% | -37↑9.6% | -41↓99.5% | -21 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -27↑13.0% | -31↑17.3% | -37↑9.6% | -41↓99.5% | -21 | |
| Bottom-Line Net Income | -27↑13.0% | -31↑17.3% | -37↑9.6% | -41↓99.5% | -21 | |
| EPS (Basic) | -0.25↑50.0% | -0.50↑62.7% | -1.34↑37.1% | -2.13↓59.0% | -1.34 | |
| EPS (Diluted) | -0.25↑50.0% | -0.50↑62.7% | -1.34↑37.1% | -2.13↓59.0% | -1.34 | |
| Weighted Average Shares | 109↑78.2% | 61↑120.3% | 28↑43.2% | 19↑25.3% | 15 | |
| Weighted Average Diluted Shares | 109↑78.2% | 61↑120.3% | 28↑43.2% | 19↑25.3% | 15 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.